Document:

Form of Lock-up Agreements

 Exhibit 10.6 
  
 Form of Lock-up Agreement for 
 Directors and Officers pursuant to Section 5(i) 
  
 FTN MIDWEST SECURITIES CORP. 
     as Representative of the several Underwriters 
 350 Madison Avenue, 20th Floor

 New York, New York 10017 
  

	 	Re:	Proposed Public Offering by Healthcare Acquisition Partners Corp. 

  
 Dear Sirs: 
 The undersigned, an officer and/or director of
Healthcare Acquisition Partners Corp., a Delaware corporation (the “Company”), and the owner of              shares of common stock (the “Shares”) of the Company,
understands that FTN Midwest Securities Corp. (the “Representative”), proposes to enter into an Underwriting Agreement with the Company with respect to the proposed consummation of a public offering of shares common stock, $0.0001 par
value, of the Company (the “Common Stock”). In recognition of the benefit that such an offering will confer upon the undersigned as the owner of the Shares and an officer and/or director of the Company, and for other good and valuable
consideration, the receipt and sufficiency of which are hereby acknowledged, the undersigned agrees with the Representative that, during a period commencing on the date hereof and ending on the date six months after the date of the consummation of a
business combination by the Company conforming to the requirements set forth in the registration statement on Form S-1 filed on October 14, 2005, as amended (the “Registration Statement”), by the Company with the Securities and Exchange
Commission under the Securities Act of 1933, as amended (the “Act”), the undersigned will not, directly or indirectly, (i) offer, pledge, sell, contract to sell, sell any option or contract to purchase, purchase any option or contract to
sell, grant any option, right or warrant for the sale of, or otherwise dispose of or transfer any shares of Common Stock, or any securities convertible into or exchangeable or exercisable for shares of Common Stock, whether now owned or hereafter
acquired (including, without limitation, any issued but not outstanding shares of Common Stock held in treasury by the Company) by the undersigned or with respect to which the undersigned has or hereafter acquires the power of disposition, or file,
or cause to be filed, any registration statement under the Act with respect to any of the foregoing (collectively, the “Lock-Up Securities”) or (ii) enter into any swap or any other agreement or any transaction that transfers, in
whole or in part, directly or indirectly, the economic consequence of ownership of the Lock-Up Securities, whether any such swap or transaction is to be settled by delivery of shares of Common Stock, options to purchase Common Stock or other
securities, in cash or otherwise. 
  
 The foregoing sentence shall
not apply to the undersigned and other persons executing agreements substantially similar to this agreement transferring Lock-Up Securities to the Company. In addition, the undersigned further agrees that no Common Stock issued from the treasury
shares may be transferred by it to the Representative or to any of Representative’s affiliates prior to the later of the date six months from the date of a business combination or twelve months after
            , 2006. If the undersigned is an affiliate of the Representative, then the undersigned cannot be released from its obligations under this agreement by the express,
written consent of the Representative prior to its expiration without the express, written consent of the Company. 
  
 If the undersigned is an affiliate of the Representative, then the undersigned cannot be released from its obligations under this agreement prior to its
expiration by the express, written consent of the Representative without the express, written consent of the Company. 
  
  

			
	 Very truly yours,

		
	 Signature:
	 	 
		
	 Print Name:
	 	 

  

 2 

  
 Form of Lock-up Agreement for

 FTN Midwest Securities Corp., pursuant to Section 5(i) 
  
 Healthcare Acquisition Partners Corp. 
 350
Madison Avenue 
 New York, NY 10017 
  

	 	Re:	Proposed Public Offering by Healthcare Acquisition Partners Corp. 

  
 Dear Sirs: 
  
 The undersigned, the holder of an option to purchase (the “Purchase Option”) 833,333 units, each composed of one share of common stock and two warrants to purchase shares of common stock of Healthcare
Acquisition Partners Corp., a Delaware corporation (the “Company”), understands that the Company proposes to consummate a public offering (the “IPO”) of shares common stock, $0.0001 par value, of the Company (“the Common
Stock”). In recognition of the benefit that such an offering will confer upon the undersigned as a optionholder of the Company, and for other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the
undersigned agrees with the Company that, the Purchase Option is exercisable at $7.50 per unit commencing on the later of the date of the consummation of a business combination by the Company conforming to the requirements set forth in the
registration statement on Form S-1 (the “business combination”) filed on October 14, 2005, as amended (the “Registration Statement”) by the Company with the Securities and Exchange Commission under the Securities Act of 1933, as
amended (the “Act”) and one year from             , 2006. 
  
 Furthermore, the undersigned will not, during a period commencing on the date hereof and ending on the date six months after the date of the consummation
of a business combination, directly or indirectly, (i) offer, pledge, sell, contract to sell, sell any option or contract to purchase, purchase any option or contract to sell, grant any option, right or warrant for the sale of, or otherwise
dispose of or transfer any options to purchase units or shares of Common Stock, or any securities convertible into or exchangeable or exercisable for Common Stock, whether now owned or hereafter acquired (including any Common Stock issued from the
treasury shares of the Company) by the undersigned or with respect to which the undersigned has or hereafter acquires the power of disposition, or file, or cause to be filed, any registration statement under the Act, as amended, with respect to any
of the foregoing (collectively, the “Lock-Up Securities”) or (ii) enter into any swap or any other agreement or any transaction that transfers, in whole or in part, directly or indirectly, the economic consequence of ownership of the
Lock-Up Securities, whether any such swap or transaction is to be settled by delivery of Common Stock (including any Common Stock issued from the treasury shares of the Company), options to purchase Common Stock or other securities, in cash or
otherwise. 
  
 Units obtained by the undersigned pursuant to the
underwriting agreement, dated             , 2006 between the Company and the undersigned, as representative of the underwriters named therein (including the over-allotment option),
as part of stabilizing transactions or pursuant to market-making activities will not be subject to this lock-up. 
  
 In addition the undersigned further agrees that no Common Stock issued from the treasury shares of the Company may be transferred to it or to any of its
affiliates prior to the later of the date six months from the date of a business combination or twelve months after             , 2006. 
  

			
	 Very truly yours,

	
	FTN MIDWEST SECURITIES CORP.
		
	 By:
	 	 
	 Name:
	 	 
	 Title:Form of Letter Agreement

 Exhibit 10.9 
  
  
 [FORM OF LETTER AGREEMENT TO BE ENTERED INTO BY
AND BETWEEN THE 
 REGISTRANT AND MEMBERS OF MANAGEMENT OTHER THAN THE INITIAL 
 STOCKHOLDERS] 
  
                             , 2006

  
 HEALTHCARE ACQUISITION PARTNERS CORP.

 350 Madison Avenue 
 New York, NY 10017 
  

			
	Re:	 	Healthcare Acquisition Partners Corp. Initial Public Offering – Letter Agreement

  
 Dear
Ladies and Gentlemen: 
  
 This letter is being delivered to you in
accordance with the Underwriting Agreement (the “Underwriting Agreement”) entered into by and between Healthcare Acquisition Partners Corp., a Delaware corporation (the “Company”), and FTN Midwest
Securities Corp., as Representative (the “Representative”) of the Underwriters named in Schedule I thereto (the “Underwriters”), relating to an underwritten initial public offering (the
“IPO”) of the Company’s units (the “Units”), each comprised of one share of the Company’s common stock, par value $0.0001 per share (the “Common Stock”), and two
warrants, each being exercisable for one share of Common Stock (each, a “Warrant”). The capitalized terms set forth on Schedule 1 attached hereto are hereby incorporated by reference herein. 
  
 In order to induce the Company and the Underwriters to enter into the
Underwriting Agreement and to proceed with the IPO and for other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the undersigned hereby agrees with the Company as follows: 
  
 1. The undersigned agrees not to acquire any IPO Shares prior to the completion of a
Business Combination.  
  
 2. In the event that the Company fails to
consummate a Business Combination within 18 months from the Effective Date of the registration statement relating to the IPO (or 24 months under the circumstances described in the prospectus relating to the IPO), the undersigned agrees to indemnify
and hold harmless the Company against any and all loss, liability, claims, damage and expense whatsoever (including, but not limited to, any and all legal or other expenses reasonably incurred in investigating, preparing or defending against any
litigation, whether pending or threatened, or any claim whatsoever) to which the Company may become subject as a result of any claim by any vendor that is owed money by the Company for services rendered or products sold but only to the extent
necessary to ensure that such loss, liability, claim, damage or expense does not reduce the amount in the Trust Account. 
  
 3. The undersigned represents and warrants that (i) the biographical information furnished to the Company and the Representative and attached hereto as
Exhibit A is true and accurate in all respects (other than de minimis errors or omissions), does not omit any material information with 

 
respect to the undersigned’s background during the previous five years and contains all of the information required to be disclosed pursuant to
Item 401 of Regulation S-K, promulgated under the Securities Act of 1933, as amended, (ii) the questionnaires furnished by the undersigned to the Company and the Representative are true and accurate in all respects (other than de minimis
errors or omissions), and (ii) the undersigned has full right and power, without violating any agreement by which the undersigned is bound, to enter into this letter agreement and to serve as
[            ][ and ][ a member of the Board of Directors] of the Company. The undersigned further represents and warrants that: 
  
 (a) The undersigned is not subject to or a respondent in any legal
action for, any injunction, cease-and-desist order or order or stipulation to desist or refrain from any act or practice relating to the offering of securities in any jurisdiction; 
  
 (b) The undersigned has never been convicted of or pleaded guilty to any crime (i) involving any fraud or
(ii) relating to any financial transaction or handling of funds of another person, or (iii) pertaining to any dealings in any securities and such person is not currently a defendant in any such criminal proceeding; and 
  
 (c) The undersigned has never been suspended or expelled from
membership in any securities or commodities exchange or association or had a securities or commodities license or registration denied, suspended or revoked. 
  
 The undersigned acknowledges and understands that the Underwriters and the Company will rely upon the agreements, representations and warranties set forth
herein in proceeding with the IPO. 
  
 This letter agreement shall
be binding on the undersigned and such person’s respective successors, heirs, personal representatives and assigns. This letter agreement shall terminate on the earlier of (i) the Business Combination Date and (ii) the Termination
Date. 
  
 This letter agreement shall be governed by and
interpreted and construed in accordance with the laws of the State of New York applicable to contracts formed and to be performed entirely within the State of New York, without regard to the conflicts of law provisions thereof to the extent such
principles or rules would require or permit the application of the laws of another jurisdiction. 
  
 No term or provision of this letter agreement may be amended, changed, waived, altered or modified except by written instrument executed and delivered by
the party against whom such amendment, change, waiver, alteration or modification is to be enforced. 
  
 [The Remainder of this Page is Intentionally Left Blank] 

  

	
	Sincerely,
	
	 
	 

  

			
	Accepted and agreed:
	
	 HEALTHCARE ACQUISITION
     PARTNERS CORP.

		
	By:	 	 
	Name: 
	 Title: 

  
  

 Schedule 1 
  

 
 SUPPLEMENTAL COMMON DEFINITIONS 
  
 Unless the context shall otherwise require, the following terms shall
have the following respective meanings for all purposes, and the following definitions are equally applicable to both the singular and the plural forms and the feminine, masculine and neuter forms of the terms defined. 
  
 “Business Combination” shall mean the acquisition by the
Company, whether by merger, capital stock exchange, asset acquisition or other similar type of combination, of one or more operating businesses in the healthcare-related sector, having, collectively, a fair market value (as calculated in accordance
with the Company’s Amended and Restated Certificate of Incorporation) of at least 80% of the Company’s net assets at the time of such merger, capital stock exchange, asset acquisition or other similar type of combination. 
  
 “Business Combination Date” shall mean the date upon which a
Business Combination is consummated. 
  
 “Effective
Date” shall mean the date upon which the Registration Statement is declared effective under the Securities Act of 1933, as amended, by the SEC. 
  
 “IPO Shares” shall mean all shares of Common Stock issued by the Company in its IPO, regardless of whether such shares were issued to an
Insider or otherwise. 
  
 “Prospectus” shall mean
the final prospectus filed pursuant to Rule 424(b) under the Securities Act of 1933, as amended, and included in the Registration Statement. 
  
 “Registration Statement” shall mean the registration statement filed by the Company on Form S-1 (No. 333-129035) with the SEC on
October 14, 2005, and any amendment or supplement thereto, in connection with the Company’s IPO. 
  
 “SEC” shall mean the United States Securities and Exchange Commission. 
  
 “Termination Date” shall mean the date that is sixty (60) calendar days immediately following the
Transaction Failure Date (inclusive thereof). 
  
 “Transaction Failure” shall mean the earlier of (i) the failure to enter into a definitive agreement with respect to a Business Combination on any day during the eighteen-month period immediately following the
Effective Date, and (ii) the failure to consummate a Business Combination on any day during the twenty four-month period immediately following the Effective Date. 
  
  

 “Transaction Failure Date” shall mean the date upon which a Transaction Failure occurs,
as conclusively established by a majority of the Independent Directors of the Company immediately following a Transaction Failure. 
  
 “Trust Account” shall mean that certain trust account established with JPMorgan Chase Bank, N.A. and in which the Company deposited the
“offering proceeds to be held in trust”, as described in the Prospectus. 
  
  

 Exhibit A 
  

 
 BIOGRAPHY 
  
 [Insert Bio here]

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00100-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00100-of-00352.parquet"}]]